Long‐term protection of the rat nigrostriatal dopaminergic system by glial cell line‐derived neurotrophic factor against 6‐hydroxydopamine in vivo

1998 ◽  
Vol 10 (1) ◽  
pp. 57-63 ◽  
Author(s):  
Sullivan ◽  
Opacka‐Juffry ◽  
Blunt
2000 ◽  
Vol 20 (15) ◽  
pp. 5587-5593 ◽  
Author(s):  
Andreas F. Hottinger ◽  
Mimoun Azzouz ◽  
Nicole Déglon ◽  
Patrick Aebischer ◽  
Anne D. Zurn

Author(s):  
BARRY J. HOFFER ◽  
JOHN HUDSON ◽  
GREG A. GERHARDT ◽  
MICHAEL A. HENRY ◽  
ALEX HOFFMAN ◽  
...  

1994 ◽  
Vol 182 (1) ◽  
pp. 107-111 ◽  
Author(s):  
Barry J. Hoffer ◽  
Alex Hoffman ◽  
Kate Bowenkamp ◽  
Peter Huettl ◽  
John Hudson ◽  
...  

1999 ◽  
Vol 7 (3) ◽  
pp. E6
Author(s):  
Vivek Mehta ◽  
Murray Hong ◽  
Julian Spears ◽  
Ivar Mendez

The goal of this study was to investigate the ability of fetal dopaminergic neurons to improve complex sensorimotor behavior. The authors obtained ventral mesencephalic tissue from 14-day-old rat fetuses. The cells were exposed to glial cell line-derived neurotrophic factor (GDNF) prior to transplantation into rats with unilateral 6-hydroxydopamine lesions of the dopaminergic nigrostriatal pathway. Animals that received 400,000 cells exposed to GDNF demonstrated significant improvement in contralateral forelimb function and showed improvement in rotational behavior faster than animals that received cells not exposed to GDNF. Increasing the number of implanted cells to 800,000 exposed to GDNF did not result in any additional improvement in functional recovery. As neural grafting procedures in the nervous system evolve and genetically engineered cells or stem cells replace fetal tissue, crucial questions about cell number and trophic regulation will need to be addressed. This study demonstrates that grafting of 400,000 cells exposed to GDNF before transplantation has a beneficial effect in the restoration of complex sensorimotor behavior.


Neuroscience ◽  
1999 ◽  
Vol 94 (2) ◽  
pp. 629-636 ◽  
Author(s):  
A.J. Eisch ◽  
C.-H. Lammers ◽  
S. Yajima ◽  
M.M. Mouradian ◽  
E.J. Nestler

2006 ◽  
Vol 20 (7) ◽  
pp. 1633-1643 ◽  
Author(s):  
Aaron Cranston ◽  
Cristiana Carniti ◽  
Sam Martin ◽  
Piera Mondellini ◽  
Yvette Hooks ◽  
...  

Abstract We report the finding of a novel missense mutation at codon 833 in the tyrosine kinase of the RET proto-oncogene in a patient with a carcinoma of the thyroid. In vitro experiments demonstrate that the R833C mutation induces transformed foci only when present in the long 3′ splice isoform and, in keeping with a model in which the receptor has to dimerize to be completely activated, glial cell line-derived neurotrophic factor stimulation leads the RETR833C receptor to a higher level of activation. Tyrosine kinase assays show that the RETR833C long isoform has weak intrinsic kinase activity and phosphorylation of an exogenous substrate is not elevated even in the presence of glial cell line-derived neurotrophic factor. Furthermore, the R833C mutation is capable of sustaining the transformed phenotype in vivo but does not confer upon the transformed cells the ability to degrade the basement membrane in a manner analogous to metastasis. Our functional characterization of the R833C substitution suggests that, like the V804M and S891A mutations, this tyrosine kinase mutation confers a weak activating potential upon RET. This is the first report demonstrating that the introduction of an intracellular cysteine can activate RET. However, this does not occur via dimerization in a manner analogous to the extracellular cysteine mutants.


Sign in / Sign up

Export Citation Format

Share Document